Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis

References

• Alami, Y., et al., 1999. HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes. Biochemical and Biophysical Research Communications, 257 (3), 738–745.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam, S.D., et al., 2019. Key molecular events in cervical cancer development. Medicina, 55 (7), 384.
   PubMedGoogle Scholar
• Bedell, S.L., et al., 2020. Cervical cancer screening: past, present, and future. Sexual Medicine Reviews, 8 (1), 28–37.
   PubMed Web of Science ®Google Scholar
• Cao, M., et al., 2020. Increased high-risk human papillomavirus viral load is associated with immunosuppressed microenvironment and predicts a worse long-term survival in cervical cancer patients. American Journal of Clinical Pathology, 153 (4), 502–512.
   PubMed Web of Science ®Google Scholar
• Castle, P.E., Einstein, M.H., and Sahasrabuddhe, V.V., 2021. Cervical cancer prevention and control in women living with human immunodeficiency virus. CA: A Cancer Journal for Clinicians, 71 (6), 505–526.
   PubMed Web of Science ®Google Scholar
• Chelimo, C., et al., 2013. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. Journal of Infection, 66 (3), 207–217.
   PubMed Web of Science ®Google Scholar
• Chen, B., et al., 2018. miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression. Molecular Medicine Reports, 18 (1), 105–112.
   PubMed Web of Science ®Google Scholar
• Cigno, I.L., et al., 2020. Subversion of host innate immunity by human papillomavirus oncoproteins. Pathogens, 9 (4), 292.
   PubMed Web of Science ®Google Scholar
• Cui, X., et al., 2020. miR-106a regulates cell proliferation and autophagy by targeting LKB1 in HPV-16-associated cervical cancer. Molecular Cancer Research, 18 (8), 1129–1141.
   PubMed Web of Science ®Google Scholar
• Dai, Y., Xie, F., and Chen, Y., 2020. Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability. FEBS Open Bio, 10 (7), 1348–1361.
   PubMed Web of Science ®Google Scholar
• de Martel, C., et al., 2017. Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer, 141 (4), 664–670.
   PubMed Web of Science ®Google Scholar
• Fang, X. and Yan, R., 2019. miR-152 inhibits the proliferation and invasion of chordoma cells by targeting HOXC8. Journal of International Medical Research, 47 (10), 5185–5193.
   PubMed Web of Science ®Google Scholar
• Fullár, A., et al., 2020. Two ways of epigenetic silencing of TFPI2 in cervical cancer. PLOS One, 15 (6), e0234873.
   PubMed Web of Science ®Google Scholar
• Gao, X., et al., 2021. LncRNA TPT1-AS1 sponges miR-23a-5p in glioblastoma to promote cancer cell proliferation. Cancer Biotherapy & Radiopharmaceuticals, 36 (7), 549–555.
   PubMed Web of Science ®Google Scholar
• Gong, C., et al., 2019. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer. Molecular Carcinogenesis, 58 (10), 1863–1875.
   PubMed Web of Science ®Google Scholar
• Gu, H., et al., 2021. The role of miR-4256/HOXC8 signaling axis in the gastric cancer progression: evidence from lncRNA–miRNA–mRNA network analysis. Frontiers in Oncology, 11, 793678.
   PubMed Web of Science ®Google Scholar
• Honegger, A., et al., 2015. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathogens, 11 (3), e1004712.
   PubMed Web of Science ®Google Scholar
• Hu, Z. and Ma, D., 2018. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Medicine, 7 (10), 5217–5236.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Chen, L., and Guo, A., 2018. Upregulated expression of HOXC8 is associated with poor prognosis of cervical cancer. Oncology Letters, 15 (5), 7291–7296.
   PubMed Web of Science ®Google Scholar
• Johnson, C.A., et al., 2019. Cervical cancer: an overview of pathophysiology and management. Seminars in Oncology Nursing, 35 (2), 166–174.
   PubMed Web of Science ®Google Scholar
• Li, H., Wu, X., and Cheng, X., 2016. Advances in diagnosis and treatment of metastatic cervical cancer. Journal of Gynecologic Oncology, 27 (4), e43.
   PubMed Web of Science ®Google Scholar
• Liu, H., et al., 2018. HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGFbeta1 in non-small cell lung cancer. Oncogenesis, 7 (2), 1.
   PubMedGoogle Scholar
• Mitra, T. and Elangovan, S., 2021. Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA. Molecular and Cellular Biochemistry, 476 (12), 4363–4385.
   PubMed Web of Science ®Google Scholar
• Purandare, N.C., et al., 2013. Exploiting biospectroscopy as a novel screening tool for cervical cancer: towards a framework to validate its accuracy in a routine clinical setting. Bioanalysis, 5 (21), 2697–2711.
   PubMed Web of Science ®Google Scholar
• Roufayel, R. and Kadry, S., 2017. Expression of miR-23a by apoptotic regulators in human cancer: a review. Cancer Biology & Therapy, 18 (5), 269–276.
   PubMed Web of Science ®Google Scholar
• Sadri, N.J., et al., 2020. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: a review. International Journal of Cancer, 146 (2), 305–320.
   PubMed Web of Science ®Google Scholar
• Saha, S.S., et al., 2017. Expression signatures of HOX cluster genes in cervical cancer pathogenesis: impact of human papillomavirus type 16 oncoprotein E7. Oncotarget, 8 (22), 36591–36602.
   PubMedGoogle Scholar
• Saliminejad, K., et al., 2019. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. Journal of Cellular Physiology, 234 (5), 5451–5465.
   PubMed Web of Science ®Google Scholar
• Shah, M., et al., 2017. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells. Molecular Cancer, 16 (1), 38.
   PubMedGoogle Scholar
• Shamseddine, A.A., et al., 2021. Tumor immunity and immunotherapy for HPV-related cancers. Cancer Discovery, 11 (8), 1896–1912.
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram, S. and You, J., 2017. Targeting persistent human papillomavirus infection. Viruses, 9 (8), 229.
   PubMed Web of Science ®Google Scholar
• Shen, S., et al., 2020. Potential role of microRNAs in the treatment and diagnosis of cervical cancer. Cancer Genetics, 248–249, 25–30.
   PubMed Web of Science ®Google Scholar
• Shen, Y., et al., 2011. Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Experimental & Molecular Medicine, 43 (6), 358–366.
   PubMed Web of Science ®Google Scholar
• Singh, G., Sharma, S.K., and Singh, S.K., 2022. miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells. BMC Cancer, 22 (1), 777.
   PubMed Web of Science ®Google Scholar
• Small, W.J., et al., 2017. Cervical cancer: a global health crisis. Cancer, 123 (13), 2404–2412.
   PubMed Web of Science ®Google Scholar
• Su, H., et al., 2022. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1. Cell Death & Disease, 13 (4), 307.
   PubMed Web of Science ®Google Scholar
• Wendel, N.R. and Leath, C.R., 2020. Advances in immunotherapy for cervical cancer. Current Opinion in Oncology, 32 (5), 481–487.
   PubMed Web of Science ®Google Scholar
• Xu, P., et al., 2015. Upregulated HOXC8 expression is associated with poor prognosis and oxaliplatin resistance in hepatocellular carcinoma. Digestive Diseases and Sciences, 60 (11), 3351–3363.
   PubMed Web of Science ®Google Scholar
• Yuan, Y., et al., 2021. HPV post-infection microenvironment and cervical cancer. Cancer Letters, 497, 243–254.
   PubMed Web of Science ®Google Scholar
• Zhang, M., et al., 2023. Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis. Acta Biochimica et Biophysica Sinica, 55 (4), 574–586.
   PubMed Web of Science ®Google Scholar
• Zhou, X., et al., 2022. LncRNA FLVCR1-AS1 mediates miR-23a-5p/SLC7A11 axis to promote malignant behavior of cervical cancer cells. Bioengineered, 13 (4), 10454–10466.
   PubMed Web of Science ®Google Scholar
• Zuo, H., et al., 2023. miR-23a-3p promotes the development of colon cancer by inhibiting the expression of NDRG4. Clinical & Translational Oncology, 25 (4), 933–940.
   PubMed Web of Science ®Google Scholar